Chemodynamic therapy (CDT) and photothermal therapy (PTT) have been powerful
technologies for tumor ablation. However, how to realize efficient CDT and PTT synergetic …

Chemoimmunotherapy, which combines chemotherapeutics with immune-modulating
agents, represents an appealing approach for improving cancer therapy. To optimize its …

Currently, vaccine is a promising tumor prevention modality in cancer therapy. However, it is
hard to elicit robust antitumor immunity in patients already afflicted with tumor, inspiring a …

Therapeutic cancer vaccines have been vigorously sought to bolster host adaptive immunity
against metastatic cancers, but tumor heterogeneity, ineffective antigen utilization, and …

In desmoplastic melanoma, tumor cells and tumor-associated fibroblasts are the major
dominators playing a critical role in the fibrosis morphology as well as the …

Paraptosis is characterized by the extensive vacuolization of endoplasmic reticulum (ER)
and mitochondria, which will cause the release of damage-associated molecular patterns to …

Reprogramming tumor‐associated macrophages (TAMs) from tumor‐supportive M2
phenotype to anti‐tumor M1 phenotype holds great promise in tumor immunotherapy …

Artificially modulating the type, density, and location of immune cells within the tumor
microenvironment can suppress tumor growth and efficiently promote current …

High expression of programmed death ligand 1 (PD-L1) and strong immune evasion ability
of the tumor microenvironment (TME) are maintained through mutual regulation between …

Cancer vaccines are viewed as a promising immunotherapy to eradicate malignant tumors
and aim to elicit the patients' own tumor-specific immune response against tumor cells …